Home » Topics » Regulatory » Patents

Patents
RSS

Dual PDE IV/TNF inhibitors from Pfizer

Feb. 12, 1997

Neurotrophic rotamase inhibitors described by Guilford

Feb. 12, 1997

Antineoplastic retinoid compounds disclosed

Feb. 12, 1997

Merck Frosst discloses leukotriene antagonists

Feb. 12, 1997

AGE inhibitors reported by Alteon

Feb. 12, 1997

Anticonvulsants with favorable protection indices reported by Canadian researchers

Feb. 12, 1997

Teva presents potential antipsoriatic agents

Feb. 12, 1997

Diagnostic MAbs from Terumo

Feb. 11, 1997

Sumitomo develops ACAT inhibitors

Feb. 11, 1997

Eisai synthesizes heterocyclic anticancer compounds

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...